Notice: Get a jump on 2015 — Pay your 2015 ASA membership dues now!

>

MEETINGS / EVENTS

RSS

January 23 - 25 2015, 12:00 AM - 12:00 AM

ASA PRACTICE MANAGEMENT 2015

February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

June 26 - 28 2015, 12:00 AM - 12:00 AM

Annual Perioperative Surgical Home Summit

>

FDA MEDWATCH ALERTS

December 18, 2014

0.9 Percent Sodium Chloride Injection USP in 100 mL MINI-BAG PLUS Container by Baxter: Recall - Particulate Matter

Summary:

FDA MedWatch Recall - Particulate Matter

November 21, 2014

FDA MedWatch - Respironics California, Esprit V1000 and V200 Ventilators: Class I Recall - Power Failure May Occur

Summary:

FDA MedWatch Respironics California Esprit V1000 and V200 Ventilators Class I Recall

November 21, 2014

FDA MedWatch - Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL by Baxter: Recall - Mislabeled

Summary:

Highly Concentrated Potassium Chloride Injection 10 mEq per 100 mL by Baxter Recall Mislabeled

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

Please Take the Company Model Survey Now

Friday, May 31, 2013

The company model continues to pose a significant problem for practicing anesthesiologists across the country.  In the company model, referring physicians or their practices set up a separate anesthesia company that they own.  The company contracts with or employs anesthesiologists and/or non-physician anesthesia providers, bills for the anesthesia service, and shares in the revenue.  The company model (including variations that result in the transfer of anesthesia fees to referring physicians) threatens the independent practice of anesthesiology and poses real legal and financial risks for anesthesiologists. 

ASA conducted its first member survey on the company model in late 2010.  The Committee on Practice Management has revised the survey and is asking ASA members to fill it out.  It is critical that ASA get updated information on the extent and impact of the company model, in order to provide real evidence to regulatory agencies about the problem. 

Take the survey now and share with your colleagues.

Thank you for your assistance.  If you have any questions about the survey, please contact Sharon Merrick, MS, CCS-P, director of payment and practice management at s.merrick@asawash.org.

The survey will remain open until June 30, 2013.

« Back to Washington Alerts